Detalles de la búsqueda
1.
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors.
Bioorg Chem
; 98: 103689, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171993
2.
Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design.
Eur J Med Chem
; 229: 114043, 2022 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34929581
3.
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
J Med Chem
; 63(4): 1642-1659, 2020 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31961685
4.
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation.
Oncotarget
; 7(52): 86239-86256, 2016 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27863392
5.
Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
J Med Chem
; 63(13): 7445, 2020 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573230
Resultados
1 -
5
de 5
1
Próxima >
>>